You are here

Call to Resume Screening and Treatment for Cancer During the COVID-19 Pandemic

 

Cancer Won’t Wait And Neither Should You

Call to Resume Screening and Treatment for Cancer During the COVID-19 Pandemic

CCCNP has joined an endorsement led by the National Comprehensive Cancer Network® (NCCN®) and the American Cancer Society (ACS) with support by 73 other leading health organizations across the country to endorse the safe resumption of cancer screening and treatment during the ongoing COVID-19 pandemic.

A coalition of 76 organizations have signed a letter to the public about the significant threat cancer poses to people’s health. The letter examines distressing trends showing a significant drop-off in recommended cancer screening and treatment during COVID-19 compared to pre-pandemic levels.

The number of people newly diagnosed with cancer has decreased significantly in the United States (U.S.) as well as in other countries across the globe during the COVID-19 pandemic. There is no evidence that the rate of new occurrences of cancer is also decreasing. These distressing trends tell us that many cancers are going undiagnosed and untreated in the wake of COVID-19. As a leading cancer organization, we join our fellow leader organizations in urging people across the country to talk with their health care provider to resume regular primary care checkups, recommended cancer screening, and evidence-based cancer treatment to lessen the negative impact of the pandemic.

Please visit acs4ccc.org/ReengageLetter to read the letter and view fellow supporters. Review the FAQs from the American Cancer Society and share this important message with your cancer control coalition and community members.

Here's a media toolkit to help share this news: